Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

3.060 -0.150 (-4.67%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agenus Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Agenus Posts 48% Q2 Revenue Miss ↗
Via The Motley Fool
News headline image
Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress
From Agenus Inc.
Via Business Wire
News headline image
Examining the Future: Agenus's Earnings Outlook ↗
 
Via Benzinga
News headline image
Agenus to Provide Corporate Update and Second Quarter 2025 Financial Report
From Agenus Inc.
Via Business Wire
News headline image
Earnings Scheduled For May 12, 2025 ↗
 
Via Benzinga
News headline image
Agenus's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2025 ↗
 
Via Benzinga
News headline image
Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025
From Agenus Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Agenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3
From Agenus Inc.
Via Business Wire
News headline image
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
From Agenus Inc.
Via Business Wire
News headline image
Agenus Announces Virtual Annual Shareholders Meeting
From Agenus Inc.
Via Business Wire
News headline image
Analyst Upgrades Agenus As Zydus Deal Alleviates Cash Overhang ↗
Zydus acquires two Agenus biologics facilities in California for $75 million, expanding U.S. CDMO presence and securing rights to key cancer drug manufacturing. 
Via Benzinga
News headline image
Agenus Stock Is Trading Higher Tuesday: What's Going On? ↗
Agenus announced it signed a partnership agreement with Zydus Lifesciences to expand patient access to Botensilimab and Balstilimab. 
Via Benzinga
News headline image
Tuesday's pre-market session: top gainers and losers ↗
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US
From Agenus Inc.
Via Business Wire
News headline image
Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Agenus Presents New Data at ASCO Highlighting Botensilimab’s Immune Activation in MSS Colorectal Cancer
From Agenus Inc.
Via Business Wire
News headline image
Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025
From Agenus Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Agenus Reports Q1 2025 Financial Results and Key Business Updates
From Agenus Inc.
Via Business Wire
News headline image
Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
From Agenus Inc.
Via Business Wire
News headline image
Agenus to Provide Corporate Update and First Quarter 2025 Financial Report
From Agenus Inc.
Via Business Wire
News headline image
Agenus’ BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR
From Agenus Inc.
Via Business Wire
News headline image
Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025
From Agenus Inc.
Via Business Wire
News headline image
Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025
From Agenus Inc.
Via Business Wire
News headline image
Here are the top movers in Tuesday's session. ↗
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
From Agenus Inc.
Via Business Wire
News headline image
Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation
From Agenus Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.